Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read More
Biotechnology
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
The deal, which was announced on the first day of the annual JPMorgan Healthcare Conference, makes J&J the latest drugmaker
Read More
Eli Lilly’s direct drug sales alone may not upend the industry, but others could follow suit
LillyDirect is the latest attempt to simplify what critics call a complex system for distributing, pricing and prescribing prescription drugs.
Read More
Florida wins first FDA approval to import cheaper drugs from Canada
Florida's plan to import drugs from Canada will likely face hurdles before it takes effect, including potential lawsuits from the
Read More
Oil prices rise more than 3% on mounting Middle East tensions, OPEC pledge to support market
Tensions in the Middle East are mounting as militants attack vessels in the Red Sea and protest in Libya shut
Read More
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot. Source link
Read More
Biden administration’s Medicare drug price negotiations will face major tests in 2024
Next year could set the precedent for the Inflation Reduction Act's controversial talks, which could affect dozens of medications by
Read More
Enphase Energy will lay off roughly 10% of workforce as part of restructuring plan
The company's stock is down 53% this year as high interest rates have depressed demand. Source link
Read More
The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead
2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance
Read More